SEER Seer, Inc.

SEER Seer, Inc.

Healthcare · Biotechnology

Market read

POC $2.18 · VWAP $2.01 · +1.1% vs 12m avg buyer

pullback vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

SEER Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist SEER belongs to, members best 30-day change first — SEER highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings SEER reports in 19 days Nov 5

Last report Aug 11

Seer furnished its earnings release to the SEC on August 11, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 the same day. No figures from these filings are recorded here.

full note →

Against street estimates

How SEER's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 11 · projection Oct 16

Result
Aug 11 -0.27-0.31-14.8%Miss
May 13 -0.29-0.30-1.7%In line
Feb 26 -0.32-0.29+9.4%Beat
Nov 6 '25 -0.30-0.32-6.7%Miss
Aug 6 '25 -0.37-0.33+11.3%Beat
May 13 '25 -0.36-0.34+6.0%Beat
Feb 27 '25 -0.39-0.37+4.4%Beat
Nov 6 '24 -0.31-0.35-13.5%Miss

SEER research tape

3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

Types